TEACHER
- Organizing Committee Members
- International Committee
- Company Presentations
- Entrepreneur Pitch
- Session 1&2 – Global Biotech Development
- Session 3 – International Collaboration Strategy
- Session 4 – Exit Strategies for Early Stage New Drug Companies
- Session 5 – New Modalities to Cure
- Session 6 - BIO Asia–Taiwan 2022 Opening & Award Ceremony
- Session 7 - Future Pandemic Preparedness
- Session 8 – Healthcare Innovation Strategy
- Session 9 – Winning the Global Competition with Taiwanese DNA
- Session 10 – AI & Digital Health
- Session 11 – Novel Platforms for Biopharma Discovery
- Session 12 – Biologics Product Development and Manufacturing
- Session 13 – Advances in Cell & Gene Therapy
- Session 14 – CDMO Business for Small Molecules
- Special Forum – Emerging Opportunities when ICT meets BIO
- Session 16- AFOB Net Zero Emission Bioeconomy
- Session 17-Life Science Ventures in Australia
- Session 18-Life Science Ventures in India
- Session 19-Life Science Ventures in Japan
- Session 20-Life Science Ventures in Singapore
- Session 21-Life Science Ventures in UK
- Session 22–Life Science Ventures in Lithuania
- Satellite Conference
Session 8 – Healthcare Innovation Strategy
Session 8 – Healthcare Innovation Strategy
Date：28 July (Thursday) 12:20 – 13:50 (GMT+8)
Venue：701EF, TaiNEX2, Taipei + Online event platform
Pertinent to the conference theme 'Connecting the Asian Value Chain', this session intitled 'Innovation Strategy' will explore collaboration and cooperation models that aim to accelerate innovation realization from academia to industry and from industry to market – in other words, from brain to bench to bedside. It's about building a sustainable innovation ecosystem, bringing in partners and experts who can help put it all together. In this luncheon session you'll learn from some of the region’s leading innovation development experts include from ITRI, Taiwan’s leading applied research institute; Janssen, a Johnson and Johnson drug development company; and others.